Trial
NCT01676701
Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Rheumatoid Arthritis
Intervention
Tabalumab Auto-Injector
Why stopped
Insufficient efficacy observed in study BCDM(NCT01198002) and BCDV(NCT01202773)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-04-26